Approval · Notice of Compliance 24735 · 2020
HUMALOG: Notice of Compliance 24735
Issued December 1, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24735
- Date
- December 1, 2020
- Company
- Eli Lilly Canada IncToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New master cell bank
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HUMALOG | Not yet assigned | — |
| HUMALOG 200U/ML KWIKPEN | Not yet assigned | — |
| HUMALOG MIX25 | Not yet assigned | — |
| HUMALOG MIX50 | Not yet assigned | — |
Medicinal ingredients
- INSULIN LISPRO 100 UNIT per ML
- INSULIN LISPRO 200 UNIT per ML
- INSULIN LISPRO 25 UNIT per ML
- INSULIN LISPRO PROTAMINE SUSPENSION 75 UNIT per ML
- INSULIN LISPRO 50 UNIT per ML
- INSULIN LISPRO PROTAMINE SUSPENSION 50 UNIT per ML